Evid Invest

BMYMP vs LLY: Valuation Comparison 2026

Side-by-side fundamentals for Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) and Eli Lilly and Company (LLY) — market cap, PE, PEG and sector. All figures from SEC filings and market data.

Bristol-Myers Squibb Company PFD CONV 2

BMYMP

Healthcare

Full BMYMP valuation →

Eli Lilly and Company

LLY

Healthcare

Full LLY valuation →
MetricBMYMPLLY
SectorHealthcareHealthcare
IndustryDrug Manufacturers - GeneralDrug Manufacturers - General
Current Price$400$1,148.5
Market Cap$814.59B$1.08T
PE Ratio112.3640.73
PEG Ratio—1.48
PEG VerdictN/AFairly Valued
BMYMP fair valueLLY fair valueBMYMP supply chainLLY supply chain

More comparisons

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.